These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38133364)

  • 1. Hepatic Transcriptome Comparative In Silico Analysis Reveals Similar Pathways and Targets Altered by Legacy and Alternative Per- and Polyfluoroalkyl Substances in Mice.
    Robarts DR; Dai J; Lau C; Apte U; Corton JC
    Toxics; 2023 Nov; 11(12):. PubMed ID: 38133364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legacy and alternative per- and polyfluoroalkyl substances (PFAS) alter the lipid profile of HepaRG cells.
    Kashobwe L; Sadrabadi F; Brunken L; Coelho ACMF; Sandanger TM; Braeuning A; Buhrke T; Öberg M; Hamers T; Leonards PEG
    Toxicology; 2024 Aug; 506():153862. PubMed ID: 38866127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
    Ojo AF; Peng C; Ng JC
    Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of novel fluorinated alternatives to long-chain perfluoroalkyl substances to human liver cell line and their binding capacity to human liver fatty acid binding protein.
    Sheng N; Cui R; Wang J; Guo Y; Wang J; Dai J
    Arch Toxicol; 2018 Jan; 92(1):359-369. PubMed ID: 28864880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human biomonitoring of per- and polyfluoroalkyl substances in German blood plasma samples from 1982 to 2019.
    Göckener B; Weber T; Rüdel H; Bücking M; Kolossa-Gehring M
    Environ Int; 2020 Dec; 145():106123. PubMed ID: 32949877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Legacy and emerging per- and polyfluoroalkyl substances (PFAS) in sediments from the East China Sea and the Yellow Sea: Occurrence, source apportionment and environmental risk assessment.
    Zhong H; Zheng M; Liang Y; Wang Y; Gao W; Wang Y; Jiang G
    Chemosphere; 2021 Nov; 282():131042. PubMed ID: 34111641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental Exposure to Emerging Alternatives of Per- and Polyfluoroalkyl Substances and Polycystic Ovarian Syndrome in Women Diagnosed with Infertility: A Mixture Analysis.
    Zhan W; Qiu W; Ao Y; Zhou W; Sun Y; Zhao H; Zhang J
    Environ Health Perspect; 2023 May; 131(5):57001. PubMed ID: 37134253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the individual and combined toxicity of perfluoroalkyl substances to human liver cells using biomarkers of oxidative stress.
    Ojo AF; Xia Q; Peng C; Ng JC
    Chemosphere; 2021 Oct; 281():130808. PubMed ID: 34022600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays.
    Evans N; Conley JM; Cardon M; Hartig P; Medlock-Kakaley E; Gray LE
    Toxicol Appl Pharmacol; 2022 Aug; 449():116136. PubMed ID: 35752307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an LC-MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO-DA, DONA, and cC6O4.
    Frigerio G; Cafagna S; Polledri E; Mercadante R; Fustinoni S
    Anal Bioanal Chem; 2022 Jan; 414(3):1259-1278. PubMed ID: 34907451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Per- and poly-fluoroalkyl substances (PFASs) in follicular fluid from women experiencing infertility in Australia.
    Kim YR; White N; Bräunig J; Vijayasarathy S; Mueller JF; Knox CL; Harden FA; Pacella R; Toms LL
    Environ Res; 2020 Nov; 190():109963. PubMed ID: 32745751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotoxicity of legacy and alternative per- and polyfluoroalkyl substances on zebrafish larvae.
    Yao D; Shao J; Jia D; Sun W
    Environ Pollut; 2024 Jul; 358():124511. PubMed ID: 38977121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.
    Rosen MB; Das KP; Rooney J; Abbott B; Lau C; Corton JC
    Toxicology; 2017 Jul; 387():95-107. PubMed ID: 28558994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Per- and polyfluoroalkyl substances (PFAS) augment adipogenesis and shift the proteome in murine 3T3-L1 adipocytes.
    Modaresi SMS; Wei W; Emily M; DaSilva NA; Slitt AL
    Toxicology; 2022 Jan; 465():153044. PubMed ID: 34800597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional pathways linked to fetal and maternal hepatic dysfunction caused by gestational exposure to perfluorooctanoic acid (PFOA) or hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) in CD-1 mice.
    Blake BE; Miller CN; Nguyen H; Chappell VA; Phan TP; Phadke DP; Balik-Meisner MR; Mav D; Shah RR; Fenton SE
    Ecotoxicol Environ Saf; 2022 Dec; 248():114314. PubMed ID: 36436258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legacy and Emerging Per- and Polyfluoroalkyl Substances: Analytical Techniques, Environmental Fate, and Health Effects.
    Brase RA; Mullin EJ; Spink DC
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental toxicity of Nafion byproduct 2 (NBP2) in the Sprague-Dawley rat with comparisons to hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) and perfluorooctane sulfonate (PFOS).
    Conley JM; Lambright CS; Evans N; Medlock-Kakaley E; Hill D; McCord J; Strynar MJ; Wehmas LC; Hester S; MacMillan DK; Gray LE
    Environ Int; 2022 Feb; 160():107056. PubMed ID: 34952357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legacy per- and polyfluoroalkyl substances (PFASs) and alternatives (short-chain analogues, F-53B, GenX and FC-98) in residential soils of China: Present implications of replacing legacy PFASs.
    Li J; He J; Niu Z; Zhang Y
    Environ Int; 2020 Feb; 135():105419. PubMed ID: 31874352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of cardiovascular effects and underlying mechanisms of legacy and emerging per- and polyfluoroalkyl substances (PFAS).
    Wen ZJ; Wei YJ; Zhang YF; Zhang YF
    Arch Toxicol; 2023 May; 97(5):1195-1245. PubMed ID: 36947184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.